Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management

Full text for this resource is not available from the Research Repository.

Chavda, Vivek P ORCID: 0000-0002-7701-8597, Patel, Aayushi B, Vora, Lalitkumar, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Uhal, Bruce (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines, 21 (10). pp. 1395-1403. ISSN 1476-0584

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/47025
DOI 10.1080/14760584.2022.2110076
Official URL https://www.tandfonline.com/doi/full/10.1080/14760...
Subjects Current > FOR (2020) Classification > 3202 Clinical sciences
Current > FOR (2020) Classification > 3204 Immunology
Current > Division/Research > Institute for Health and Sport
Keywords pandemic; immunotherapy; clinical trials; COVID-19 vaccine; SARS-CoV-2; dendritic cells
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login